Industry: Pharmaceutical
Challenge: High risk of compliance failure in sterile manufacturing, impacting regulatory approvals and revenue.
Approach: Developed quality frameworks, implemented risk-based remediation measures, and engaged regulatory experts.
Results: Achieved FDA compliance with zero major observations, securing $500M+ in uninterrupted revenue.